-
1
-
-
0037107346
-
The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity
-
Blum D., Gall D., Galas M.C., d'Alcantara P., Bantubungi K., Schiffmann S.N. The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity. J. Neurosci. 2002, 22:9122-9133.
-
(2002)
J. Neurosci.
, vol.22
, pp. 9122-9133
-
-
Blum, D.1
Gall, D.2
Galas, M.C.3
d'Alcantara, P.4
Bantubungi, K.5
Schiffmann, S.N.6
-
2
-
-
0038231381
-
Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics
-
Blum D., Hourez R., Galas M.C., Popoli P., Schiffmann S.N. Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics. Lancet Neurol. 2003, 2:366-374.
-
(2003)
Lancet Neurol.
, vol.2
, pp. 366-374
-
-
Blum, D.1
Hourez, R.2
Galas, M.C.3
Popoli, P.4
Schiffmann, S.N.5
-
3
-
-
0038113064
-
A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists
-
Blum D., Galas M.C., Pintor A., Brouillet E., Ledent C., Muller C.E., et al. A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists. J. Neurosci. 2003, 23:5361-5369.
-
(2003)
J. Neurosci.
, vol.23
, pp. 5361-5369
-
-
Blum, D.1
Galas, M.C.2
Pintor, A.3
Brouillet, E.4
Ledent, C.5
Muller, C.E.6
-
4
-
-
84930348600
-
Adenosine receptors in Huntington's disease
-
Springer
-
Blum D., Martire A., Burnouf S., Sablonnière B., Krystkowiak P., Ledent C., et al. Adenosine receptors in Huntington's disease. Adenosine: A Key Link Between Metabolism and CNS Activity 2012, 409-434. Springer.
-
(2012)
Adenosine: A Key Link Between Metabolism and CNS Activity
, pp. 409-434
-
-
Blum, D.1
Martire, A.2
Burnouf, S.3
Sablonnière, B.4
Krystkowiak, P.5
Ledent, C.6
-
5
-
-
77957600542
-
Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies
-
Chen J.F., Chern Y. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies. Handb. Exp. Pharmacol. 2011, 200:267-310.
-
(2011)
Handb. Exp. Pharmacol.
, vol.200
, pp. 267-310
-
-
Chen, J.F.1
Chern, Y.2
-
6
-
-
77956195136
-
What knock-out animals tell us about the effects of caffeine
-
Chen J.F., Yu L., Shen H.Y., He J.C., Wang X., Zheng R. What knock-out animals tell us about the effects of caffeine. J. Alzheimers Dis. 2010, 20:S17-S24.
-
(2010)
J. Alzheimers Dis.
, vol.20
-
-
Chen, J.F.1
Yu, L.2
Shen, H.Y.3
He, J.C.4
Wang, X.5
Zheng, R.6
-
7
-
-
20244362093
-
CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model
-
Chou S.Y., Lee Y.C., Chen H.M., Chiang M.C., Lai H.L., Chang H.H., et al. CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model. J. Neurochem. 2005, 93:310-320.
-
(2005)
J. Neurochem.
, vol.93
, pp. 310-320
-
-
Chou, S.Y.1
Lee, Y.C.2
Chen, H.M.3
Chiang, M.C.4
Lai, H.L.5
Chang, H.H.6
-
8
-
-
68249143292
-
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease
-
Dhaenens C.M., Burnouf S., Simonin C., Vanbrussel E., Duhamel A., Defebvre L., et al. A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiol. Dis. 2009, 35:474-476.
-
(2009)
Neurobiol. Dis.
, vol.35
, pp. 474-476
-
-
Dhaenens, C.M.1
Burnouf, S.2
Simonin, C.3
Vanbrussel, E.4
Duhamel, A.5
Defebvre, L.6
-
9
-
-
0345561561
-
Actions of caffeine in the brain with special reference to factors that contribute to its widespread use
-
Fredholm B.B., Bättig K., Holmén J., Nehlig A., Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 1999, 51:83-133.
-
(1999)
Pharmacol. Rev.
, vol.51
, pp. 83-133
-
-
Fredholm, B.B.1
Bättig, K.2
Holmén, J.3
Nehlig, A.4
Zvartau, E.E.5
-
10
-
-
80053960641
-
Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease
-
Giralt A., Saavedra A., Carretón O., Xifró X., Alberch J., Pérez-Navarro E. Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease. Hum. Mol. Genet. 2011, 20:4232-4247.
-
(2011)
Hum. Mol. Genet.
, vol.20
, pp. 4232-4247
-
-
Giralt, A.1
Saavedra, A.2
Carretón, O.3
Xifró, X.4
Alberch, J.5
Pérez-Navarro, E.6
-
11
-
-
79959352258
-
A new drug design targeting the adenosinergic system for Huntington's disease
-
Huang N.K., Lin J.H., Lin J.T., Lin C.I., Liu E.M., Lin C.J., et al. A new drug design targeting the adenosinergic system for Huntington's disease. PLoS One 2011, 6:e20934.
-
(2011)
PLoS One
, vol.6
-
-
Huang, N.K.1
Lin, J.H.2
Lin, J.T.3
Lin, C.I.4
Liu, E.M.5
Lin, C.J.6
-
12
-
-
0034711708
-
Rate of functional decline in Huntington's disease. Huntington Study Group
-
Marder K., Zhao H., Myers R.H., Cudkowicz M., Kayson E., Kieburtz K., et al. Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology 2000, 54:452-458.
-
(2000)
Neurology
, vol.54
, pp. 452-458
-
-
Marder, K.1
Zhao, H.2
Myers, R.H.3
Cudkowicz, M.4
Kayson, E.5
Kieburtz, K.6
-
13
-
-
78650609433
-
A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease
-
Mievis S., Blum D., Ledent C. A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease. Neurobiol. Dis. 2011, 41:570-576.
-
(2011)
Neurobiol. Dis.
, vol.41
, pp. 570-576
-
-
Mievis, S.1
Blum, D.2
Ledent, C.3
-
14
-
-
84873711954
-
Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis
-
Potenza R.L., Armida M., Ferrante A., Pèzzola A., Matteucci A., Puopolo M., Popoli P. Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. Res. 2013, 91:585-592.
-
(2013)
J. Neurosci. Res.
, vol.91
, pp. 585-592
-
-
Potenza, R.L.1
Armida, M.2
Ferrante, A.3
Pèzzola, A.4
Matteucci, A.5
Puopolo, M.6
Popoli, P.7
-
15
-
-
84899158383
-
Modulatory effect of coffee fruit extract on plasma levels of brain-derived neurotrophic factor in healthy subjects
-
Reyes-Izquierdo T., Nemzer B., Shu C., Huynh L., Argumedo R., Keller R., Pietrzkowski Z. Modulatory effect of coffee fruit extract on plasma levels of brain-derived neurotrophic factor in healthy subjects. Br. J. Nutr. 2013, 14:1-6.
-
(2013)
Br. J. Nutr.
, vol.14
, pp. 1-6
-
-
Reyes-Izquierdo, T.1
Nemzer, B.2
Shu, C.3
Huynh, L.4
Argumedo, R.5
Keller, R.6
Pietrzkowski, Z.7
-
16
-
-
77954763359
-
Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption
-
Rogers P.J., Hohoff C., Heatherley S.V., Mullings E.L., Maxfield P.J., Evershed R.P., et al. Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology 2010, 35:1973-1983.
-
(2010)
Neuropsychopharmacology
, vol.35
, pp. 1973-1983
-
-
Rogers, P.J.1
Hohoff, C.2
Heatherley, S.V.3
Mullings, E.L.4
Maxfield, P.J.5
Evershed, R.P.6
-
17
-
-
78650031174
-
Huntington's disease: from molecular pathogenesis to clinical treatment
-
Ross C.A., Tabrizi S.J. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011, 10:83-98.
-
(2011)
Lancet Neurol.
, vol.10
, pp. 83-98
-
-
Ross, C.A.1
Tabrizi, S.J.2
-
18
-
-
84866378617
-
Chronic caffeine prevents changes in inhibitory avoidance memory and hippocampal BDNF immunocontent in middle-aged rats
-
Sallaberry C., Nunes F., Costa M.S., Fioreze G.T., Ardais A.P., Botton P.H., Klaudat B., Forte T., Souza D.O., Elisabetsky E., Porciúncula L.O. Chronic caffeine prevents changes in inhibitory avoidance memory and hippocampal BDNF immunocontent in middle-aged rats. Neuropharmacology 2013, 64:153-159.
-
(2013)
Neuropharmacology
, vol.64
, pp. 153-159
-
-
Sallaberry, C.1
Nunes, F.2
Costa, M.S.3
Fioreze, G.T.4
Ardais, A.P.5
Botton, P.H.6
Klaudat, B.7
Forte, T.8
Souza, D.O.9
Elisabetsky, E.10
Porciúncula, L.O.11
-
19
-
-
79955393453
-
Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption
-
Sulem P., Gudbjartsson D.F., Geller F., Prokopenko I., Feenstra B., Aben K.K., et al. Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Hum. Mol. Genet. 2011, 20:2071-2077.
-
(2011)
Hum. Mol. Genet.
, vol.20
, pp. 2071-2077
-
-
Sulem, P.1
Gudbjartsson, D.F.2
Geller, F.3
Prokopenko, I.4
Feenstra, B.5
Aben, K.K.6
-
20
-
-
84870394065
-
Calcium leak through ryanodine receptor is involved in neuronal death induced by mutant huntingtin
-
Suzuki M., Nagai Y., Wada K., Koike T. Calcium leak through ryanodine receptor is involved in neuronal death induced by mutant huntingtin. Biochem. Biophys. Res. Commun. 2012, 429:18-23.
-
(2012)
Biochem. Biophys. Res. Commun.
, vol.429
, pp. 18-23
-
-
Suzuki, M.1
Nagai, Y.2
Wada, K.3
Koike, T.4
-
21
-
-
78650059716
-
Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1
-
Taherzadeh-Fard E., Saft C., Wieczorek S., Epplen J.T., Arning L. Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1. Neurogenetics 2010, 11:435-439.
-
(2010)
Neurogenetics
, vol.11
, pp. 435-439
-
-
Taherzadeh-Fard, E.1
Saft, C.2
Wieczorek, S.3
Epplen, J.T.4
Arning, L.5
-
22
-
-
78349297184
-
Role of adenosine A(2A) receptors in modulating synaptic functions and brain levels of BDNF: a possible key mechanism in the pathophysiology of Huntington's disease
-
Tebano M.T., Martire A., Chiodi V., Ferrante A., Popoli P. Role of adenosine A(2A) receptors in modulating synaptic functions and brain levels of BDNF: a possible key mechanism in the pathophysiology of Huntington's disease. ScientificWorldJournal. 2010, 10:1768-1782.
-
(2010)
ScientificWorldJournal.
, vol.10
, pp. 1768-1782
-
-
Tebano, M.T.1
Martire, A.2
Chiodi, V.3
Ferrante, A.4
Popoli, P.5
-
23
-
-
0035348156
-
Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin
-
Varani K., Rigamonti D., Sipione S., Camurri A., Borea P.A., Cattabeni F., Abbracchio M.P., Cattaneo E. Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin. FASEB J. 2001, 15:1245-1247.
-
(2001)
FASEB J.
, vol.15
, pp. 1245-1247
-
-
Varani, K.1
Rigamonti, D.2
Sipione, S.3
Camurri, A.4
Borea, P.A.5
Cattabeni, F.6
Abbracchio, M.P.7
Cattaneo, E.8
-
24
-
-
33846225133
-
Huntington's disease
-
Walker F.O. Huntington's disease. Lancet 2007, 369:218-228.
-
(2007)
Lancet
, vol.369
, pp. 218-228
-
-
Walker, F.O.1
|